Cargando…

Tumor-targeted IL-12 combined with tumor resection yields a survival-favorable immune profile

BACKGROUND: Although accumulated evidence provides a strong scientific premise for using immune profiles to predict survival in patients with cancer, a universal immune profile across tumor types is still lacking, and how to achieve a survival-associated immune profile remains to be evaluated. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Qingnan, Hu, Jiemiao, Mitra, Abhisek, Cutrera, Jeffry, Zhang, Wendong, Zhang, Zhongting, Yan, Jun, Xia, Xueqing, Mahadeo, Kris Michael, Livingston, John Andrew, Gorlick, Richard, Li, Shulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580640/ https://www.ncbi.nlm.nih.gov/pubmed/31208461 http://dx.doi.org/10.1186/s40425-019-0631-z

Ejemplares similares

Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors
por: Hu, Jiemiao, et al.
Publicado: (2022)

Induction of NKG2D ligand expression on tumor cells by CD8(+) T cell engagement-mediated activation of nuclear factor-kappa B and p300/CBP-associated factor
por: Hu, Jiemiao, et al.
Publicado: (2019)

WSX1 Expression in Tumors Induces Immune Tolerance via Suppression of Effector Immune Cells
por: Dibra, Denada, et al.
Publicado: (2011)

IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skin
por: Dibra, Denada, et al.
Publicado: (2016)

IL12 immune therapy clinical trial review: Novel strategies for avoiding CRS-associated cytokines
por: Jia, Zhiliang, et al.
Publicado: (2022)

Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
por: Hu, Jiemiao, et al.
Publicado: (2021)

A microfluidics-based method for isolation and visualization of cells based on receptor-ligand interactions
por: Dao, Long, et al.
Publicado: (2022)

Intricacies for Posttranslational Tumor-Targeted Cytokine Gene Therapy
por: Cutrera, Jeffry, et al.
Publicado: (2013)

Generation of a monoclonal antibody against the glycosylphosphatidylinositol-linked protein Rae-1 using genetically engineered tumor cells
por: Hu, Jiemiao, et al.
Publicado: (2014)

WSX1 act as a tumor suppressor in hepatocellular carcinoma by downregulating neoplastic PD-L1 expression
por: Wu, Man, et al.
Publicado: (2021)

CD8(+)T cell–specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8(+)T cell accumulation in tumors
por: Hu, Jiemiao, et al.
Publicado: (2014)

Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells
por: Noh, Hyangsoon, et al.
Publicado: (2015)

EMT, CTCs and CSCs in tumor relapse and drug-resistance
por: Mitra, Abhisek, et al.
Publicado: (2015)

Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy
por: Cutrera, Jeffry, et al.
Publicado: (2015)

Potential Function of Exogenous Vimentin on the Activation of Wnt Signaling Pathway in Cancer Cells
por: Satelli, Arun, et al.
Publicado: (2016)

FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells
por: Zhao, Qingnan, et al.
Publicado: (2023)

Herceptin Conjugates Linked by EDC Boost Direct Tumor Cell Death via Programmed Tumor Cell Necrosis
por: Hu, Jiemiao, et al.
Publicado: (2011)

Peripheral Tumor Location Predicts a Favorable Prognosis in Patients with Resected Small Cell Lung Cancer
por: Gao, Yina, et al.
Publicado: (2022)

Detection of circulating tumor DNA in patients with osteosarcoma
por: Barris, David M., et al.
Publicado: (2018)

Tumor-infiltrating IL-17A(+) cells determine favorable prognosis and adjuvant chemotherapeutic response in muscle-invasive bladder cancer
por: Wang, Zewei, et al.
Publicado: (2020)

Wide resection and reconstruction of giant cell tumor of the distal humerus with favorable outcomes in 3 months: A case report
por: Guntur, Putera, et al.
Publicado: (2022)

FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Minimally Invasive Spine Metastatic Tumor Resection and Stabilization: New Technology Yield Improved Outcome
por: Harel, Ran, et al.
Publicado: (2015)

Tumor-infiltrating macrophages express interleukin-25 and predict a favorable prognosis in patients with gastric cancer after radical resection
por: Li, Jinqing, et al.
Publicado: (2016)

Cytoskeleton-centric protein transportation by exosomes transforms tumor-favorable macrophages
por: Chen, Zhipeng, et al.
Publicado: (2016)

IL-22-mediates Cross-talk between Tumor Cells and Immune Cells Associated with Favorable Prognosis in Human Colorectal Cancer
por: Droeser, Raoul André, et al.
Publicado: (2021)

Favorable Alteration of Tumor Microenvironment by Immunomodulatory Cytokines for Efficient T-Cell Therapy in Solid Tumors
por: Tähtinen, Siri, et al.
Publicado: (2015)

Circadian disruption promotes tumor-immune microenvironment remodeling favoring tumor cell proliferation
por: Aiello, I., et al.
Publicado: (2020)

Author Correction: FGL2 promotes tumor progression in the CNS by suppressing CD103(+) dendritic cell differentiation
por: Yan, Jun, et al.
Publicado: (2019)

Association and Validation of Yield-Favored Alleles in Chinese Cultivars of Common Wheat (Triticumaestivum L.)
por: Guo, Jie, et al.
Publicado: (2015)

Tumor-Derived Lactate Creates a Favorable Niche for Tumor via Supplying Energy Source for Tumor and Modulating the Tumor Microenvironment
por: Jin, Mengyao, et al.
Publicado: (2022)

The Organ Trail: A Review of Biomarkers of Organ Failure
por: Dao, Long, et al.
Publicado: (2020)

Rare Tumor of Conus Medullaris in an Adult with a Favorable Outcome
por: Kumar, Ashish, et al.
Publicado: (2012)

Won’t you come on in? How to favor lymphocyte infiltration in tumors
por: Bellone, Matteo, et al.
Publicado: (2012)

Predictive factors for residual tumor and tumor upstaging on relook transurethral resection of bladder tumor in non-muscle invasive bladder cancer
por: Gill, Tejpal S., et al.
Publicado: (2014)

High Endothelial Venule with Concomitant High CD8+ Tumor-Infiltrating Lymphocytes Is Associated with a Favorable Prognosis in Resected Gastric Cancer
por: Hong, Soon Auck, et al.
Publicado: (2020)

Integration of the Tumor Mutational Burden and Tumor Heterogeneity Identify an Immunological Subtype of Melanoma With Favorable Survival
por: Gao, Yanmei, et al.
Publicado: (2020)

Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: A case report
por: Oe, Yuki, et al.
Publicado: (2021)

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
por: Wen, Xiaosha, et al.
Publicado: (2022)

Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer
por: Sun, Xueqing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_edo0dqfpkmr7okq8prc9bfg4eb